• Oser, C., Haven, J., Staton-Tindall, M., Wong, C., Leukefeld, C., & Prendergast, M. (2008). HIV sexual risk behaviors among ketamine and non-ketamine using prison inmates. Addiction Research and Theory, 16(3), 289-302.
• Oser, C., & Roman, P. (2008). Organizational adoption of naltrexone: A categorical typology of private substance abuse treatment centers. Journal of Substance Abuse Treatment, 34(4), 433-442.
• Oser, C., Haven, J., Mooney, J., Staton-Tindall, M., Knudsen, H., Duvall, J., & Leukefeld, C. (2008). Racial differences in HIV/AIDS communication strategoies and sexual risk behaviors among drug abusing female criminal offenders. Journal of Psychoactive Drugs, 40(4), 1-31.

Current Projects

Dr. Carrie Oser is the Principal Investigator on a National Institute on Drug Abuse (NIDA) supported project entitled “African American Female Drug Users: HIV, Health Disparities, and Criminality.”  The overall goal of this project is to understand how drug use and criminality are related to health disparities, particularly HIV, and service utilization among African American drug using and non-drug using women across criminal justice status (i.e., prison, jail, probation, and non-offenders in the community).  She is also PI on a NIDA career development award which will examine the impact of clients’ characteristics, the counselor context, and the treatment facilities’ attributes on client-level behavioral treatment outcomes in both rural and urban areas.  In addition, Dr. Oser is a co-PI on the NIDA CJ-DATS cooperative agreement to develop, implement, and evaluate treatment interventions for substance using offenders transitioning from correctional facilities to the community.